Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,352.00
Bid: 12,350.00
Ask: 12,354.00
Change: -46.00 (-0.37%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,482.00
Low: 12,340.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Lloyds declines as state investment vehicle lowers stake, miners lower

Mon, 01st Jun 2015 13:49

UK shares were trading lower on Monday afternoon, ahead of a raft of US economic data, as weakness in mining, oil and insurance stocks outweighed gains made in the real estate, travel and electronics sectors.As of 15:30 BST, the FTSE 100 was trading 0.23% lower at 6,988.Lloyds registered losses as UK Financial Investments, the state investment vehicle, lowered its stake to 18.99% from the 19.93% it held on 12 May. The move follows continued market speculation surrounding the timing public share-selling, with the aim of returning the lender wholly to private ownership, possibly as early as September.Morrison dipped ahead of this week's annual meeting, as investors are expected to object to former chief executive Dalton Phillips's substantial payoff. The company is also at risk of being removed from the FTSE 100 altogether, to be replaced by satellite communications group Inmarsat.Prudential was also weaker as it appointed Barry Stowe as chairman and chief executive of its North American business.Miners Fresnillo, Anglo American and Glencore were in the red following weak manufacturing data from China, the world's biggest metals consumer. Oil giants Weir Group and Shell also declined, as oil prices retreated from last week's highs.Shell was also hit with allegations that it tried to use its connections with the Science Museum to influence the presentation of its Climate Change programme. A leaked internal email expressed concerns that a particular part of the project sponsored by the company "creates an opportunity for NGOs [non-governmental organisations] to talk about some of the issues that concern them around Shell's operations".Astrazeneca was boosted by positive takeaways from the annual meeting of the American Society of Clinical Oncology, during which the company presented preliminary data for one of its lung cancer drugs.WPP was trading higher, despite reports that it could face opposition from shareholders at its annual meeting on 9 June over chief executive Martin Sorrell's £43m pay award for 2014. Glass Lewis and Institutional Shareholder Services (ISS), which advise investors that own about a quarter of the equities on the UK stock market, have both raised concerns about the 40% increase, according to The Financial Times.RisersAshtead Group (AHT) 1,155.00p +3.12%Dixons Carphone (DC.) 485.40p +2.10%International Consolidated Airlines Group SA (CDI) (IAG) 564.00p +1.81%British Land Company (BLND) 877.00p +1.74%St James's Place (STJ) 926.00p +1.59%Intertek Group (ITRK) 2,540.00p +1.56%InterContinental Hotels Group (IHG) 2,781.00p +1.46%Land Securities Group (LAND) 1,332.00p +1.45%Lloyds Banking Group (LLOY) 88.95p +1.34%Taylor Wimpey (TW.) 185.80p +1.25%FallersWeir Group (WEIR) 1,978.00p -2.27%Standard Chartered (STAN) 1,033.00p -1.24%Glencore (GLEN) 284.65p -1.15%Royal Dutch Shell 'B' (RDSB) 1,956.00p -0.89%Anglo American (AAL) 1,017.00p -0.88%Imperial Tobacco Group (IMT) 3,341.00p -0.86%Kingfisher (KGF) 366.90p -0.84%Barclays (BARC) 268.10p -0.70%Aggreko (AGK) 1,597.00p -0.68%Mondi (MNDI) 1,466.00p -0.68%
More News
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.